Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Nanotechnology-based vs Microneedling-assisted Tranexamic Acid in Melasma
NCT07887399Not yet recruiting
- Sponsor
- Sohag University
- Start
- Oct 2026
- Primary completion
- Feb 2027
- Countries
- 1
01
Overview
Randomised, open-label trial of tranexamic acid in melasma (3 arms), sponsored by Sohag University. Primary endpoint: Melasma Area and Severity Index at 4 months. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
tranexamic acid
03
Conditions
melasma
Beyond the preview
Go deeper on NCT07887399.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07887399.